|
NMI expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.03529995476981E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.20790000410909E-08 |
| Normal-vs-Stage2 |
4.775000E-04 |
| Normal-vs-Stage3 |
1.649890E-04 |
| Normal-vs-Stage4 |
2.695400E-03 |
| Stage1-vs-Stage2 |
1.818570E-01 |
| Stage1-vs-Stage3 |
9.791700E-02 |
| Stage1-vs-Stage4 |
8.452100E-02 |
| Stage2-vs-Stage3 |
6.052600E-01 |
| Stage2-vs-Stage4 |
6.217800E-01 |
| Stage3-vs-Stage4 |
9.984800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.15420001228972E-09 |
| Normal-vs-AfricanAmerican |
1.47309999976031E-07 |
| Normal-vs-Asian |
5.936100E-02 |
| Caucasian-vs-AfricanAmerican |
8.393200E-01 |
| Caucasian-vs-Asian |
2.649200E-01 |
| AfricanAmerican-vs-Asian |
2.825000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1150999840458E-09 |
| Normal-vs-Female |
1.11319999884785E-08 |
| Male-vs-Female |
2.770800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.842600E-04 |
| Normal-vs-Extreme_Weight |
5.90230000430125E-08 |
| Normal-vs-Obese |
1.02170000015889E-07 |
| Normal-vs-Extreme_Obese |
4.082300E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.359980E-01 |
| Normal_Weight-vs-Obese |
5.574000E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.572600E-01 |
| Extreme_Weight-vs-Obese |
4.314200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.446800E-01 |
| Obese-vs-Extreme_Obese |
1.790210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.96770000000002E-05 |
| Normal-vs-Age(41-60Yrs) |
3.09160474998293E-11 |
| Normal-vs-Age(61-80Yrs) |
6.15569999973253E-07 |
| Normal-vs-Age(81-100Yrs) |
3.352500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.446100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.220900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.386400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.695400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.969800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.569800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.0919999893797E-10 |
| Normal-VS-Type2 PRCC |
3.277600E-03 |
| Normal-VS-KIRP CIMP |
5.572400E-04 |
| Normal-VS-Unclassified PRCC |
1.24040000004655E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.595400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.724300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.489180E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.616600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.083300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.325370E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.73850000000564E-05 |
| Normal-vs-N1 |
3.17500000002191E-06 |
| Normal-vs-N2 |
1.939630E-01 |
| N0-vs-N1 |
5.056500E-03 |
| N0-vs-N2 |
4.632800E-01 |
| N1-vs-N2 |
8.736000E-02 |
|
|
